The role of screening for prostate cancer has been questioned, and urologists remain the primary specialists with knowledge of the importance of this intervention. Management options for prostate and other urologic tumors have rapidly evolved with increased consideration of surveillance, watchful waiting, ablative treatments as well as surgical and multimodal therapies, creating a knowledge gap for practicing urologists. The lectures and discussions in this activity will fulfill these educational needs.
Target audience: past and current faculty and residents of the Brady Department of Urology, as well as urologists practicing in the New York Metropolitan Area.
Course Goals & Objectives
At the conclusion of this program, all participants should be able to:
Weill Cornell Medicine gratefully acknowledges funding provided in part by the Frederick J. and Theresa Dow Wallace Fund and New York Community Trust .
Saturday, October 14, 2017
Weill Cornell Medical College, A950
1300 York Avenue, New York NY